Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Sweden
/
Pharmaceuticals & Biotech
Create a narrative
Swedencare
OM:SECARE Community
1
Narratives
written by author
0
Comments
on narratives written by author
2
Fair Values set
on narratives written by author
Create a narrative
Swedencare
Popular
Undervalued
Overvalued
Swedencare
WA
Analyst Price Target
Consensus Narrative from 3 Analysts
Resolving NaturVet's Challenges And Global Expansion Will Enhance Future Opportunities
Key Takeaways Improved growth strategy for NaturVet and global market expansion aim to enhance revenue and achieve group targets. Focus on local manufacturing and strategic innovations is set to increase market share, operational efficiency, and earnings growth.
View narrative
SEK 58.67
FV
21.5% undervalued
intrinsic discount
12.97%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
3 days ago
author updated this narrative
Your Valuation for
SECARE
Swedencare
Your Fair Value
SEK
Current Price
SEK 46.08
24.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
4b
2015
2018
2021
2024
2025
2027
2030
Revenue SEK 4.3b
Earnings SEK 165.8m
Advanced
Set as Fair Value